Diagnostic performance of axial T2-weighted MRI sequence for exclusion of brain tumour in paediatric patients with non-localizing symptoms.

Autor: Gerrish AC; Radiology, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, United Kingdom., Malik L; Radiology, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, United Kingdom., Swain C; Radiology, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, United Kingdom., Thomas AG; Radiology, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, United Kingdom., Jaspan T; Radiology, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, United Kingdom., Dineen RA; Radiology, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, United Kingdom.; Radiological Sciences, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, United Kingdom.; Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, NG7 2UH, United Kingdom.; NIHR Nottingham Biomedical Research Centre, Nottingham, NG7 2UH, United Kingdom.

Publikováno v: The British journal of radiology [Br J Radiol] 2024 Dec 02. Date of Electronic Publication: 2024 Dec 02.

Pattern of brain metastatic disease according to HER-2 and ER receptor status in breast cancer patients

Autor: Lekanidi, K., Evans, A.L., Shah, J., Jaspan, T., Baker, L., Evans, A.J.

Publikováno v: In Clinical Radiology October 2013 68(10):1070-1073

Relapsed intracranial ependymoma in children in the UK: Patterns of relapse, survival and therapeutic outcome

Autor: Messahel, B., Ashley, S., Saran, F., Ellison, D., Ironside, J., Phipps, K., Cox, T., Chong, W.K., Robinson, K., Picton, S., Pinkerton, C.R., Mallucci, C., Macarthur, D., Jaspan, T., Michalski, A., Grundy, R.G.

Publikováno v: In European Journal of Cancer 2009 45(10):1815-1823

Applying machine learning classifiers to automate quality assessment of paediatric dynamic susceptibility contrast (DSC-) MRI data.

Autor: Powell SJ; Physical Sciences for Health CDT, University of Birmingham, Birmingham, United Kingdom.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Withey SB; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Department of Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom.; RRPPS, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Sun Y; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, China., Grist JT; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Novak J; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Department of Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom.; Department of Psychology, Aston Brain Centre, School of Life and Health Sciences, Aston University, Birmingham, United Kingdom., MacPherson L; Radiology, Birmingham Children's Hospital, Birmingham, United Kingdom., Abernethy L; Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom., Pizer B; Oncology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom., Grundy R; The Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, United Kingdom., Morgan PS; The Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, United Kingdom.; Medical Physics, Nottingham University Hospitals, Nottingham, United Kingdom.; NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom., Jaspan T; The Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, United Kingdom.; Radiology, Nottingham University Hospitals, Nottingham, United Kingdom., Bailey S; Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom., Mitra D; Neuroradiology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., Auer DP; Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom., Avula S; Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom., Arvanitis TN; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Department of Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom.; Institute of Digital Healthcare, WMG, University of Warwick, Coventry, United Kingdom., Peet A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Department of Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom.

Publikováno v: The British journal of radiology [Br J Radiol] 2023 Apr 01; Vol. 96 (1145), pp. 20201465. Date of Electronic Publication: 2023 Feb 20.

MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial.

Autor: Rodriguez D; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Calmon R; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Aliaga ES; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Warren D; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Warmuth-Metz M; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Jones C; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Mackay A; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Varlet P; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Le Deley MC; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Hargrave D; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Cañete A; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Massimino M; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Azizi AA; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Saran F; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Zahlmann G; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Garcia J; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Vassal G; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Grill J; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Peet A; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Dineen RA; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Morgan PS; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.)., Jaspan T; From the Department of Medical Physics and Clinical Engineering (D.R., P.S.M.) and Department of Radiology (R.A.D., T.J.), Nottingham University Hospitals Trust, Derby Rd, Nottingham NG7 2UH, England; Mental Health & Clinical Neurosciences Unit, University of Nottingham, Nottingham, England (D.R., R.A.D., P.S.M.); Department of Pediatric Radiology, Necker Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (R.C.); Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands (E.S.A.); Department of Radiology, Leeds Teaching Hospitals, Leeds, England (D.W.); Institute for Diagnostic and Interventional Neuroradiology, Würzburg University, Würzburg, Germany (M.W.M.); Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, England (C.J., A.M.); Department of Pathological Anatomy and Cytology, Centre Hospitalier Sainte Anne, Paris, France (P.V.); Department of Biostatistics, Centre Oscar Lambret, Lille, France (M.C.L.D.); Department of Haematology and Oncology, Great Ormond Street Hospital, London, England (D.H.); Pediatric Oncology and Hematology Unit, Hospital La Fe, Valencia, Spain (A.C.); Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M.); Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria (A.A.A.); Auckland Radiation Oncology, Auckland City Hospital, New Zealand. (F.S.); F. Hoffmann-La Roche, Basel, Switzerland (G.Z., J. Garcia); Department of Pediatric and Adolescent Oncology and Unit 981 from the Institut National de la Santé et de la Recherche Médicale, Gustave Roussy, Université Paris-Saclay, Université Paris-Sud, Villejuif, France (G.V., J. Grill); and Institute of Cancer and Genomic Sciences, University of Birmingham, and Birmingham Children's Hospital, Birmingham, England (A.P.).

Publikováno v: Radiology [Radiology] 2022 Jul; Vol. 304 (1), pp. 174-182. Date of Electronic Publication: 2022 Apr 12.